Clinical trials sponsored by Second Affiliated Hospital of Guangzhou Medical University

Phase breakdown

Conditions studied

Recruiting trials led by Second Affiliated Hospital of Guangzhou Medical University

• A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
  NCT07675746 · Phase: Early Phase 1 · Ages: 2 Years to 18 Years · Sex: All (male and female) · 1 location
• Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
  NCT06483347 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
  NCT05341492 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
  NCT04842812 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• GPC3/Mesothelin-CAR-γδT Cells Against Cancers
  NCT06196294 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
  NCT03198052 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
  NCT04770207 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers
  NCT05779917 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
  NCT06492421 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
  NCT03778814 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
  NCT04803318 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
  NCT03755739 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus
  NCT07374328 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
  NCT05187338 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 3 locations

Common questions

How many trials is Second Affiliated Hospital of Guangzhou Medical University recruiting for?

Second Affiliated Hospital of Guangzhou Medical University is the lead sponsor of 14 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.